Aptevo Therapeutics, Inc. (APVO)
1.76
0.00 (0.00%)
USD |
NASDAQ |
Oct 02, 16:00
1.80
+0.04
(+2.27%)
Pre-Market: 08:36
Aptevo Therapeutics Price : 1.76 for Oct. 2, 2026
Price Chart
Historical Price Data
| Date | Open | High | Low | Close | Volume |
|---|---|---|---|---|---|
| Oct 02, 2026 | 1.80 | 1.80 | 1.76 | 1.76 | 12571.00 |
| Oct 01, 2026 | 1.820 | 1.84 | 1.75 | 1.76 | 25083.00 |
| Sep 30, 2026 | 1.84 | 1.90 | 1.81 | 1.82 | 25256.00 |
| Sep 29, 2026 | 1.90 | 1.91 | 1.84 | 1.86 | 15025.00 |
| Sep 28, 2026 | 1.86 | 1.98 | 1.86 | 1.91 | 47827.00 |
| Sep 25, 2026 | 1.83 | 1.90 | 1.818 | 1.89 | 25478.00 |
| Sep 24, 2026 | 1.88 | 1.90 | 1.81 | 1.83 | 32969.00 |
| Sep 23, 2026 | 1.88 | 1.895 | 1.800 | 1.89 | 54316.00 |
| Sep 22, 2026 | 1.814 | 1.89 | 1.814 | 1.85 | 39432.00 |
| Sep 21, 2026 | 1.842 | 1.89 | 1.805 | 1.81 | 22437.00 |
| Sep 18, 2026 | 1.85 | 1.890 | 1.82 | 1.84 | 41298.00 |
| Sep 17, 2026 | 1.79 | 1.90 | 1.73 | 1.84 | 425020.0 |
| Sep 16, 2026 | 1.710 | 1.80 | 1.710 | 1.72 | 54075.00 |
| Sep 15, 2026 | 1.81 | 1.84 | 1.71 | 1.71 | 48827.00 |
| Sep 14, 2026 | 1.854 | 1.895 | 1.80 | 1.80 | 46139.00 |
| Sep 11, 2026 | 1.83 | 1.92 | 1.80 | 1.82 | 45091.00 |
| Sep 10, 2026 | 1.82 | 1.88 | 1.76 | 1.83 | 56835.00 |
| Sep 09, 2026 | 1.89 | 1.99 | 1.82 | 1.845 | 43910.00 |
| Sep 08, 2026 | 1.77 | 1.93 | 1.745 | 1.88 | 168841.0 |
| Sep 04, 2026 | 1.74 | 1.796 | 1.64 | 1.74 | 272973.0 |
| Sep 03, 2026 | 2.11 | 2.18 | 1.37 | 1.71 | 1.690M |
| Sep 02, 2026 | 2.34 | 2.77 | 2.33 | 2.60 | 1.028M |
| Sep 01, 2026 | 2.44 | 2.44 | 2.34 | 2.34 | 31994.00 |
| Aug 31, 2026 | 2.35 | 2.45 | 2.35 | 2.44 | 29794.00 |
| Aug 28, 2026 | 2.46 | 2.46 | 2.31 | 2.365 | 21678.00 |
Price Definition
The price of a security measures the cost to purchase 1 share of a security. For a company, price can be multiplied by shares outstanding to find the market capitalization (value of the company).
Price Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price Benchmarks
| Arrowhead Pharmaceuticals, Inc. | 64.19 |
| Oncolytics Biotech, Inc. | 0.631 |
| Sangamo Therapeutics, Inc. | 0.1475 |
| Sarepta Therapeutics, Inc. | 17.50 |
| Anixa Biosciences, Inc. | 2.95 |
Price Related Metrics
| Price to Book Value | 0.4134 |
| Earnings Yield | -3.28K% |
| Market Cap | 2.497M |